Education
About Us
Working with TipRanks
Follow Us
biote (BTMD)
NASDAQ:BTMD
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.08Last Year’s EPS
-0.19Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: 17.96%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there were notable achievements such as revenue growth, improved profit margins, and strong performance in the dietary supplements segment, these were offset by challenges, including a decrease in procedure revenue, reduced adjusted EBITDA, and increased SG&A expenses. The company is undergoing a strategic realignment aimed at driving growth, but the impacts of these changes may take time to materialize.Company Guidance
In the first quarter of 2025, biote Corp. provided guidance indicating strong financial performance with a reported total revenue increase of 4.7% to $49 million compared to the same period in 2024. Despite a 3.6% decrease in procedure revenue to $36 million, dietary supplement revenue showed significant growth, increasing by 25.5% to $9.3 million, largely driven by the success of the e-commerce channel. The company's gross profit margin improved by 300 basis points to 74.3%, attributed to the vertical integration of their 503B manufacturing facility. Adjusted EBITDA decreased by 3.4% to $13.8 million, with an adjusted EBITDA margin of 28.1%. For the fiscal year 2025, biote Corp. maintained its guidance of achieving total revenue between $202 million and $208 million, and adjusted EBITDA ranging from $59 million to $64 million. The company also anticipates a one-time restructuring charge of $600,000 to $800,000 in the second quarter of 2025.Increase in Total Revenue
Total revenue increased by 4.7% compared to the same period in 2024, reaching $49 million.
Improvement in Gross Profit Margin
Gross profit margin increased by 300 basis points to 74.3% due to the vertical integration of the 503B manufacturing facility.
Strong Performance in Dietary Supplements
Dietary supplement revenue increased by 25.5% to $9.3 million, primarily driven by growth in the e-commerce channel.
Increased Cash and Cash Equivalents
Cash and cash equivalents were $41.7 million as of March 31, 2025, up from $39.3 million as of December 31, 2024.
---
BTMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BTMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2025 | $3.34 | $3.74 | +11.98% |
Mar 12, 2025 | $4.10 | $3.07 | -25.12% |
Nov 12, 2024 | $5.52 | $6.72 | +21.74% |
Aug 08, 2024 | $6.77 | $5.49 | -18.91% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does biote (BTMD) report earnings?
biote (BTMD) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is biote (BTMD) earnings time?
biote (BTMD) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BTMD EPS forecast?
BTMD EPS forecast for the fiscal quarter 2025 (Q2) is 0.08.
---